ArticleScientific reports2025
Atopic dermatitis-related anti-inflammatory in vitro effects of a plant extract mixture.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- GC-Ms, UHPLC-MS/MSChemistry & biodiversity · 2026Article
- Plant extract mixture shows anti-inflammatory and barrier-strengthening effects and activates aryl hydrocarbon receptor in a 2D psoriasis model.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The chronic inflammatory skin disease atopic dermatitis (AD) is characterized by barrier defects, inflammation and microbial dysbiosis with a high prevalence of Staphylococcus (S.) aureus. Previously, we reported that a plant extract mixture consisting of curly kale, green tea and apple had beneficial effects on AD. Herein we further investigated the underlying promising effects exerted by the plant extract. The extract exhibited direct antimicrobial activity against S. aureus and reduced the number of extra- and intracellular S. aureus in keratinocytes. Gene expression analyses and luciferase reporter assays in 2D and 3D AD-like skin models showed activation of the aryl hydrocarbon receptor (AhR) by the plant extract. Knockdown experiments with siRNA revealed an AhR-dependent induction of the skin barrier molecule filaggrin by the plant extract in the AD skin model. Moreover, the plant extract demonstrated antioxidative properties by reduction of intracellular reactive oxygen species and induction of the antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1). In conclusion, the antioxidant and antibacterial effects of the plant extract in combination with the AhR activation may be promising for the topical treatment of AD. Further research has to uncover the full potential of plant extracts for the treatment of AD and other inflammatory diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.